A Ropes & Gray IP cross-practice team, on July 10, obtained two major wins for clients medac Pharma, Inc. and medac GmbH (collectively, medac) defeating a citizen’s petition brought by rival Antares Pharma, Inc. (Antares) in the FDA to preclude the FDA from approving medac’s RASUVO™ system for the treatment of rheumatoid arthritis and defeating a motion for preliminary injunction to prevent medac’s US launch of RASUVO™ in a suit brought by Antares, in the District of Delaware, alleging patent infringement of Antares’s patents directed to needle-assisted jet injectors with hazardous agents. The team included IP rights management partner Jim Haley (New York).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.